Table 2.
Outcome | Predictor | Parameter estimate | Statistical significance |
---|---|---|---|
Myocardial fat, % | Age, years | 0.056 | P = 0.012 |
Hepatic fat, % | 0.099 | P = 0.013 | |
Fasting glucose, mg/dl | 0.095 | P < 0.001 | |
Visceral fat/BSA | 0.013 | NS | |
Serum triglyceride level, mg/dl | –0.0007 | NS | |
Duration of ART, years | 0.042 | NS | |
Strain relaxation index, ms | Age, years | 0.021 | NS |
ECV, % | 0.157 | P = 0.017 | |
EDM/BSA | 0.033 | NS | |
EDM/EDV | –0.575 | NS | |
Peak circumferential systolic strain, Ecc | Age, years | 0.111 | NS |
EDM/BSA | 0.163 | P = 0.036 | |
EDM/EDV | 18.69 | P < 0.01 |
BSA, body surface area; ART, antiretroviral therapy; ECV, extracellular volume fraction; EDM, end diastolic mass; EDV, end diastolic volume; NS, no significant association (P > 0.05).